Summarized by Daily Strand AI from peer-reviewed source
Deep inside our brains, tiny cells called pericytes wrap around our blood vessels. They act as microscopic regulators, keeping blood flow steady and maintaining the blood-brain barrier, a strict security system that prevents harmful substances from leaking into brain tissue. To understand exactly what happens when these crucial cells disappear, researchers used a genetic technique to selectively remove brain pericytes in an animal model. They found that different types of pericytes along the blood vessel network have their own unique vulnerabilities when depleted.
When the brain experiences a moderate loss of pericytes, a cascade of temporary but serious problems begins. Blood flow drops, and the blood-brain barrier becomes abnormally permeable. Without pericytes to keep them in check, the cells lining the smallest blood vessels, known as capillary endothelial cells, undergo a radical change. They reprogram themselves into an activated, inflamed state. During this transformation, they increase production of a protein called VCAM-1 while reducing expression of MFSD2A, a crucial transporter protein.
This molecular reprogramming acts as a trigger for wider brain damage, specifically harming the heavily insulated wiring of the brain known as white matter. Researchers compared their findings across different species to see how this translates to human health. They discovered that the genetic changes seen in the altered animal blood vessels closely match the gene signatures found in humans suffering from small vessel disease.
Small vessel disease is a major culprit behind cognitive decline and neurovascular issues in human patients. By pinpointing pericyte loss as a root cause of blood vessel inflammation and white matter injury, scientists now have a clearer map of how this destructive process begins. This research reveals that blood vessels do not just passively degenerate. Instead, the loss of pericytes actively forces the vessel lining to change its behavior and become harmful to the surrounding brain tissue.
For the future of medicine, these findings point to potential new targets for drug development. If therapies can be designed to protect pericytes or block the harmful reprogramming of the blood vessel lining, it might be possible to halt the progression of small vessel disease early on. However, researchers caution that these discoveries are based on early-stage preclinical animal models. Direct clinical confirmation in human patients will be absolutely necessary before these insights can be turned into new medical treatments.
Interested in General Biotech?
Newsletter
Never miss a breakthrough.
Join 10,000+ curious minds getting biotech stories distilled into plain language. Free, three times a week.